Radiopharm Theranostics (RADX) Shares Outstanding (Weighted Average) (2024 - 2025)

Radiopharm Theranostics (RADX) reported Shares Outstanding (Weighted Average) of $1.3 billion for Q2 2025, up 423.3% year-over-year from $254.7 million in Q2 2024, and up 423.3% quarter-over-quarter from $254.7 million in Q2 2024.

Radiopharm Theranostics (RADX) Shares Outstanding (Weighted Average) (2024 - 2025) Analysis & Trends

Radiopharm Theranostics (RADX) has 2 years of Shares Outstanding (Weighted Average) data on file, last reported at $1.3 billion in Q2 2025.

  • Shares Outstanding (Weighted Average) for Q2 2025 came in at $1.3 billion, up 423.3% year-over-year; the trailing twelve-month figure through Jun 2025 was $1.3 billion (up 423.3% YoY), and the FY2025 annual result was $176.6 million, up 75.36% from the prior year.
  • Shares Outstanding (Weighted Average) rose to $1.3 billion in Q2 2025 per RADX's latest filing, from $254.7 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $1.3 billion in Q2 2025 and troughed at $254.7 million in Q2 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 Radiopharm Theranostics 5.82 Bn 5.81 Bn - 1.33 Bn

Historic Data

Download Data
DateValue
Jun 30, 2025 1.33 Bn
Jun 30, 2024 254.69 Mn